HEPA insider transactions
Hepion Pharmaceuticals Inc. (HEPA) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for HEPA
- New insider Lopriore Chase claimed ownership of 1,250,000 shares (SEC Form 3)3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- Director Purcell Michael J. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- Executive Chairman Lopriore Vincent S bought $250,000 worth of shares (6,250,000 units at $0.04) (SEC Form 4)4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- Interim CEO Stetz Gary S. bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- Director Appajosyula Sireesh bought $50,000 worth of shares (1,250,000 units at $0.04) (SEC Form 4)4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by new insider Stetz Gary S.3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by Hepion Pharmaceuticals Inc.3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by Hepion Pharmaceuticals Inc.3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Purcell Michael J.4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by new insider Purcell Michael J.3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Jacob Gary S4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Block Timothy M.4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Lbiati Kaouthar4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Brancaccio John P4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- Wijngaard Peter bought $15,350 worth of shares (5,000 units at $3.07), increasing direct ownership by 111% to 9,501 units (SEC Form 4)4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: Wijngaard Peter bought $16,841 worth of shares (3,000 units at $5.61), increasing direct ownership by 200% to 4,501 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: Foster Robert T bought $8,960 worth of shares (1,600 units at $5.60), increasing direct ownership by 3% to 50,470 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: Foster Robert T bought $8,640 worth of shares (1,600 units at $5.40), increasing direct ownership by 3% to 48,870 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by new insider Lbiati Kaouthar3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 3 filed by new insider Reddi Anand3 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Lippa Arnold4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Wijngaard Peter4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by Cavan John T4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by BRANCACCIO JOHN P4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4 filed by ADAMS THOMAS PHD4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: Peter Wijngaard bought $22,000 worth of Common Stock (10,000 units at $2.20), increasing ownership by 50% to 30,000 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: T John Cavan bought $20,000 worth of Common Stock (10,000 units at $2.00), increasing ownership by 208% to 14,800 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)
- SEC Form 4: T Robert Foster bought $40,000 worth of Common Stock (20,000 units at $2.00), increasing ownership by 79% to 45,259 units4 - Hepion Pharmaceuticals, Inc. (0001583771) (Issuer)